![]() |
![]() ![]() |
´ëÇѾȰúÇÐȸ ´ë±¸°æºÏÁöȸ ¿¬¼ö±³À°-¹é³»Àå ¹× Àü¾ÈºÎ ÃֽŠÁö°ß : 2024-05-21 |
|
´ëÇѾȰúÇÐȸ ´ë±¸°æºÏÁöȸ ¿¬¼ö±³À°-¹é³»Àå ¹× Àü¾ÈºÎ ÃֽŠÁö°ß : 2024-05-21 ±³À°ÁÖÁ¦ : ´ëÇѾȰúÇÐȸ ´ë±¸°æºÏÁöȸ ¿¬¼ö±³À°-¹é³»Àå ¹× Àü¾ÈºÎ ÃֽŠÁö°ß ÁÖÃÖ±â°ü : ´ëÇѾȰúÇÐȸ ´ã´çÀÚ : ¹®Á¾¿ø À̸ÞÀÏ : ananto@naver.com ±³À°Á¾·ù : ¾È°ú Âü¼®¿¹»óÀÎ : 100¸í Áö¿ª : ´ë±¸±¤¿ª½Ã ¼¼ºÎ¼ö°·á : 10,000¿ø ºñ°í
½Ä»ç 05¿ù 21ÀÏ - 19:00~19:30 ½Ä»ç -(-) ±³À°½Ã°£ 05¿ù 21ÀÏ ¸µÅ©È¦ 19:30~20:20 IOL power : Targeting emmetropia ÀÌÁØÈÆ(¾ÆÀ̹é¾È°ú) Åä·Ð 05¿ù 21ÀÏ ¸µÅ©È¦ 20:20~20:30 Q&A ÀÌÁØÈÆ(¾ÆÀ̹é¾È°ú) ±³À°½Ã°£ 05¿ù 21ÀÏ ¸µÅ©È¦ 20:30~21:20 Diagnosis and treatment of neurotrophic keratopathy À±¼÷Çö(´ë±¸°¡Å縯´ëÇк´¿ø) Åä·Ð 05¿ù 21ÀÏ ¸µÅ©È¦ 21:20~21:30 Q&A À±¼÷Çö(´ë±¸°¡Å縯´ëÇк´¿ø)
|
Tip. ±³À°ÀÏÁ¤Àº ±³À°±â°üÀÇ »çÁ¤¿¡ µû¶ó º¯°æµÉ ¼ö ÀÖÀ¸¹Ç·Î »çÀü¿¡ ¹Ýµå½Ã ±³À°±â°üÀ¸·Î ¹®ÀÇÇÏ¿© È®ÀÎ ¹Ù¶ø´Ï´Ù. | ![]() |
|
![]() ![]() |
![]() ![]() |